Literature DB >> 2062459

The effect of Ca2+ channel antagonists (cadmium, omega-conotoxin GIVA, and nitrendipine) on the release of angiotensin II from fetal rat brain in vitro.

A P Gadbut1, S A Cash, J A Noble, T R Radice, J A Weyhenmeyer.   

Abstract

We have shown previously that K+ stimulation of dissociated cell cultures of fetal rat brain results in a graded release of angiotensin II (ANG II) that is dependent on the availability of extracellular Ca2+. In this study, using dissociated cell cultures of fetal rat hypothalamus, thalamus, septum, and midbrain (HTSM), we further examined the role of calcium channels on ANG II release using specific channel blockers (cadmium, omega-conotoxin, and nitrendipine) and a calcium ionophore (A23187). Levels of ANG II release were quantitated by radioimmunoassay and HPLC. For control levels of ANG II release, cells were incubated in a stock buffer containing 89 mM choline chloride/58 mM KCl/2 mM CaCl2. Pretreatment of the cells with either 100 microM Cd2+ (to block N-, L-, and T-type calcium channels), 100 nM omega-conotoxin (to block N- and L-type calcium channels), or 500 nM nitrendipine (to block L-type calcium channels) decreased ANG II release by approximately 71%, 71% and 22%, respectively, when compared to control levels. In contrast, pretreatment of the cells with 1.6 microM A23187 (a calcium ionophore) increased ANG II release by approximately 90% over control levels. These findings suggest that angiotensin release is dependent on the intracellular entry of Ca2+ ions through primarily N-type channels, and to a lesser extent, L-type channels.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2062459     DOI: 10.1016/0304-3940(91)90165-p

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  1 in total

Review 1.  Development of fetal brain renin-angiotensin system and hypertension programmed in fetal origins.

Authors:  Caiping Mao; Lijun Shi; Feichao Xu; Lubo Zhang; Zhice Xu
Journal:  Prog Neurobiol       Date:  2009-01-24       Impact factor: 11.685

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.